Differences in 18F-FDG Uptake and Expression of Glucose Transporter Between 2 Distinct Subtypes of Mass-Forming Intrahepatic Cholangiocarcinomas-Reference-Cited by-同舟云学术

Differences in 18F-FDG Uptake and Expression of Glucose Transporter Between 2 Distinct Subtypes of Mass-Forming Intrahepatic Cholangiocarcinomas

Published:2020-06 Issue:6 Volume:45 Page:e267-e273
ISSN:1536-0229
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:Clin Nucl Med

Author:

Kozaka Kazuto,Kobayashi Satoshi,Takamura Hiroyuki,Sato Yasunori,Kitao Azusa,Inoue Dai,Yoneda Norihide,Tajima Hidehiro,Kinuya Seigo,Harada Kenichi,Ohta Tetsuo,Koda Wataru,Matsui Osamu,Gabata Toshifumi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference31 articles.

1. Reappraisal of prognostic impact of tumor SUVmax by (18)F-FDG-PET/CT in intrahepatic cholangiocarcinoma;World J Surg,2019

2. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA);Nat Rev Gastroenterol Hepatol,2016

3. Pathologic classification of cholangiocarcinoma: new concepts;Best Pract Res Clin Gastroenterol,2015

4. Peribiliary glands: development, dysfunction, related conditions and imaging findings;Abdom Radiol (NY),2019

5. Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes;J Surg Oncol,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing 18F-FDG PET/CT Uptake and its Correlation with Molecular Biomarkers in Penile Cancer;Nuclear Medicine and Molecular Imaging;2024-08-30

2. Detection of GLUT-1, Hexokinase-Ii, Ki-67, P53, and P16 Levels and HPV With 18F-Fdg PET/CT in Penile Cancer;2023-07-31

3. Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [18F]F-FDG PET/CT in Patients with Liver Malignancies;Molecular Imaging and Biology;2022-04-29

4. Diagnostic Applications of Nuclear Medicine: Tumors of the Liver and Biliary Tract;Nuclear Oncology;2022

5. Diagnostic Applications of Nuclear Medicine: Tumors of the Liver and Biliary Tract;Nuclear Oncology;2022